Investment objective & strategy
As of April 28, 2025 · prospectusObjective. The Fund seeks long-term growth of capital.
Strategy. The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of investment) in equity securities, or other investments with similar economic characteristics, of U.S. large-capitalization companies. FIAM LLC, the Fund's subadviser (the "Subadviser"), defines large-capitalization companies as companies with market capitalizations similar to companies in the Russell 1000 Growth Index (the "Index") at the time of purchase. Although expected to change frequently, the market capitalization range of the Index was approximately $681 million to $3.3 trillion as of March 31, 2025. The Fund is classified as "non-diversified" under the Investment Company Act of 1940 (the "1940 Act"). The Fund may invest in foreign equity securities, either directly … The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of investment) in equity securities, or other investments with similar economic characteristics, of U.S. large-capitalization companies. FIAM LLC, the Fund's subadviser (the "Subadviser"), defines large-capitalization companies as companies with market capitalizations similar to companies in the Russell 1000 Growth Index (the "Index") at the time of purchase. Although expected to change frequently, the market capitalization range of the Index was approximately $681 million to $3.3 trillion as of March 31, 2025. The Fund is classified as "non-diversified" under the Investment Company Act of 1940 (the "1940 Act"). The Fund may invest in foreign equity securities, either directly or through depositary receipts. The Fund's foreign investments are mainly in developed markets. The Subadviser emphasizes individual security selection while allocating the Fund's investments across industries, which is intended to reduce risk. The Subadviser invests the fund's assets in companies it believes have above-average growth potential. Growth may be measured by factors such as earnings or revenue. Companies with high growth potential tend to be companies with higher than average price/earnings (P/E) or price/book (P/B) ratios. Companies with strong growth potential often have new products, technologies, distribution channels, or other opportunities, or have a strong industry or market position. The stocks of these companies are often called "growth" stocks. Some reasons that could persuade the Subadviser to sell investments include negative earnings revisions, deterioration in business fundamentals, unreasonably high valuations, or an unexpected change in business strategy.
Top holdings
As of March 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| NVIDIA CORP | — | $18.02M | 11.98% |
| AMAZON.COM INC | — | $15.33M | 10.20% |
| ALPHABET INC CL A | — | $10.82M | 7.19% |
| APPLE INC | — | $7.77M | 5.17% |
| META PLATFORMS INC CL A | — | $5.31M | 3.53% |
| TAIWAN SEMIC MFG CO LTD SP ADR | — | $5.28M | 3.51% |
| LILLY ELI and CO | — | $4.89M | 3.25% |
| ROYALTY PHARMA PLC | — | $4.37M | 2.90% |
| MICROSOFT CORP | — | $4.15M | 2.76% |
| BROADCOM INC | — | $2.94M | 1.96% |
Portfolio moves
Dec 31, 2025 → Mar 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Large-Cap Growth Portfolio | 96% | 0.66% |
| AVIP Fidelity Institutional AM Equity Growth Portfolio | 92% | 0.79% |
| Fidelity Equity Growth K6 Fund · FEGKX | 57% | 0.45% |
Advisers
| Firm | Role |
|---|---|
| FIAM LLC | Sub-adviser |
| Park Avenue Institutional Advisers LLC | Adviser |
Footnotes
- Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.